Abstract.
The present study was conducted to characterise the centrally active analgesic drug tramadol hydrochloride [(1RS,2RS)-2-[(dimethyl-amino)-methyl]-1-(3-methoxyphenyl)-cyclohexanol hydrochloride] and its metabolites M1, M2, M3, M4 and M5 at the cloned human µ-opioid receptor. Membranes from stably transfected Chinese hamster ovary (CHO) cells were used to determine the four parameters of the ligand-receptor interaction: the affinity of (±)-tramadol and its metabolites was determined by competitive inhibition of [3H]naloxone binding under high and low salt conditions. The agonist-induced stimulation of [35S]GTPγS binding permits the measurement of potency (EC50), efficacy (E max = maximal stimulation) and relative intrinsic efficacy (effect as a function of receptor occupation). The metabolite (+)-M1 showed the highest affinity (K i=3.4 nM) to the human µ-opioid receptor, followed by (±)-M5 (K i=100 nM), (-)-M1 (K i=240 nM) and (±)-tramadol (K i=2.4 µM). The [35S]GTPγS binding assay revealed an agonistic activity for the metabolites (+)-M1, (-)-M1 and (±)-M5 with the following rank order of intrinsic efficacy: (+)-M1>(±)-M5>(-)-M1. The metabolites (±)-M2, (±)-M3 and (±)-M4 displayed only weak affinity (K i>10 µM) and had no stimulatory effect on GTPγS binding. These data indicate that the metabolite (+)-M1 is responsible for the µ-opioid-derived analgesic effect.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Gillen, C., Haurand, M., Kobelt, D. et al. Affinity, potency and efficacy of tramadol and its metabolites at the cloned human µ-opioid receptor. Naunyn-Schmied Arch Pharmacol 362, 116–121 (2000). https://doi.org/10.1007/s002100000266
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002100000266